mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice
Diana Wing Lee, Arshan Nasir, Sayda M. Elbashir, Hardik Jani, Tessa Speidel, Amy Gorrie, Daniela Montes Berrueta, Philippa Martin, Swan Tan, Yixuan Jacob Hou, Kath Hardcastle, Darin K. Edwards, Kai Wu, Andrea Carfı́, Yadunanda Budigi
This study evaluates JN.1 and KP.2 mRNA vaccines in mice, showing they elicit strong neutralizing antibodies against JN.1 subvariants and cross-neutralize KP.3, LA.2, and XEC.
Vaccine · Mar 7, 2025Peer-reviewedImmunology